Breztri Aerosphere 160 mcg

BREZTRI AEROSPHERE 160 MCG is an inhaled corticosteroid used for managing asthma and chronic obstructive pulmonary disease (COPD). This metered-dose aerosol helps reduce inflammation in the lungs, improving breathing. Ideal for those seeking effective respiratory support.

BREZTRI AEROSPHERE 160 MCG is primarily used for the maintenance treatment of asthma and COPD. It works by reducing inflammation in the airways, which can help prevent asthma attacks and manage COPD symptoms. This medication is often prescribed for long-term use to maintain lung function and improve quality of life.

Common effects of BREZTRI AEROSPHERE 160 MCG may include a reduction in asthma symptoms such as wheezing, shortness of breath, and coughing. Users may also experience improved lung function and fewer flare-ups. Some individuals might notice mild throat irritation or a dry mouth after use.

It is important to use BREZTRI AEROSPHERE 160 MCG as directed by a healthcare professional. Always follow the prescribed dosage and administration instructions. Avoid using this medication if you are allergic to budesonide or any of its components. Regular monitoring of lung function may be recommended.

BREZTRI AEROSPHERE 160 MCG may interact with other medications, including certain antifungal drugs, antibiotics, and HIV protease inhibitors. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.